Melanie Sulistio, M.D., Ramavathi Nandyala, M.D., Michael Lujan, B.S., Adrienne S. Zion, Ph.D., and Robert Chilton, D.O., F.A.C.C.
People with diabetes are three times more likely to have a cardiovascular event than those without diabetes. This article covers the mechanisms responsible for this disparity as well as assessment and optimal management strategies for the individual patient.
Complications and comorbidities — Cardiovascular disease
Larry J. Suva, Ph.D., and Ruth L. Thomas, M.D.
Drs. Suva and Thomas review the current understanding of the effect of thiazolidinediones on bone and provide some evidence-based answers to questions arising from the increased rate of fractures in Type 2 patients.
Drug treatment — Thiazolidinediones
Aruna Venkatesh, M.D.
This article reviews the endocannabanoid system and the advances that have led to the development of endocannabanoid-receptor antagonists, as well as clinical trials using rimonabant for treating obesity in patients with dyslipidemia and diabetes.
Complications and comorbidities — Obesity
Neal W. Pollock, Ph.D.
People with diabetes who want to participate in recreational diving can, providing certain criteria are met. Dr. Pollock outlines the recent—and very clear—guidelines of the Undersea and Hyperbaric Medical Society and the Divers Alert Network.
Management strategies and tools — Physical activity
Special activities with diabetes — Scuba diving
Martha M. Funnell, M.S., R.N., C.D.E.
Every five years, the diabetes community reviews these standards to ensure that they remain relevant and reflect available evidence. The author reviews the 2007 standards—in particular, significant changes in four areas.
Education — Self-management strategies
Charles A. Reasner, M.D.